SUNRISE PHARMA LIMITED Financials
- Company number
- 07393155CopyCopy
- Registered office
- 226 Sandy Lane, Droylsden, Manchester M43 7JX
- Incorporated
- 30/09/2010
Company snapshot
- Status
- Active
- Employees
- 6 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
185.79%vs 20242024: £-28.89K
Total Assets
-72.43%vs 20242024: £456.87K
Cash in Bank
79.01%vs 20242024: £96.59K
Total Liabilities
-99.83%vs 20242024: £485.76K
Employees
0vs 20242024: 6
In 2025, SUNRISE PHARMA LIMITED reported net assets of £24.78K. The same filing shows total assets of £125.97K, cash in bank of £172.90K and total liabilities of £818.00. Reported headcount was 6 in 2025. Total Liabilities fell from £485.76K in 2024 to £818.00 in 2025 (-99.83%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
185.79%from £-28.89K in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures SUNRISE PHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
Increasedvs 2023Cash in Bank
-40.2%vs 2023-22.7% a year compound (CAGR)
Total Assets
-77.5%vs 2023-52.6% a year compound (CAGR)
Total Liabilities
-99.9%vs 2023-96.4% a year compound (CAGR)
Employees
0%vs 2023Biggest decrease
Total Liabilities-99.9%
£630.09K in 2023 to £818.00 in 2025
SUNRISE PHARMA LIMITED's filings pull in both directions between 2023 and 2025. The steepest fall came in total liabilities, pointing to lighter outstanding obligations, with cash in bank and total assets falling alongside it. See the full year-by-year figures.
Ratios from the filed figures
Calculated from SUNRISE PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 19.67%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 0.65%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 21,137.29%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 137.26%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for SUNRISE PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | -156.57K | -117.35K | -69.23K | -28.89K | 24.78K |
| Total Assets£ | 462.59K | 528.08K | 560.85K | 456.87K | 125.97K |
| Cash in Bank£ | 139.26K | 262.12K | 289.01K | 96.59K | 172.90K |
| Total Liabilities£ | 619.15K | 645.43K | 630.09K | 485.76K | 818.00 |
| Employees | 6 | 7 | 6 | 6 | 6 |
SUNRISE PHARMA LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for SUNRISE PHARMA LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
SUNRISE PHARMA LIMITED reported net assets of £24.78K for 2025. That compares with £-28.89K in 2024, a change of 185.79%.
SUNRISE PHARMA LIMITED reported total assets of £125.97K for 2025. That compares with £456.87K in 2024, a change of -72.43%.
SUNRISE PHARMA LIMITED reported cash in bank of £172.90K for 2025. That compares with £96.59K in 2024, a change of 79.01%.
SUNRISE PHARMA LIMITED reported 6 employees in 2025, compared with 6 in 2024.
Between 2023 and 2025, SUNRISE PHARMA LIMITED's cash in bank fell by 40.2%, total assets fell by 77.5%, total liabilities fell by 99.9% and employee numbers was unchanged. Cash in bank contracted at 22.7% a year across the two years to 2025, from £289.01K to £172.90K. Reported headcount went from 6 in 2023 to 6 in 2025.
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.